Predictive value of ERCC1, ERCC2, ERCC4, and glutathione S-Transferase Pi expression for the efficacy and safety of FOLFIRINOX in patients with unresectable pancreatic cancer

about

Predictive value of ERCC1, ERCC2, ERCC4, and glutathione S-Transferase Pi expression for the efficacy and safety of FOLFIRINOX in patients with unresectable pancreatic cancer

Item

http://www.wikidata.org/entity/Q58790011

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Predictive value of ERCC1, ERC ...... unresectable pancreatic cancer

@en

Predictive value of ERCC1, ERC ...... unresectable pancreatic cancer

@nl

type

Item

label

Predictive value of ERCC1, ERC ...... unresectable pancreatic cancer

@en

Predictive value of ERCC1, ERC ...... unresectable pancreatic cancer

@nl

prefLabel

Predictive value of ERCC1, ERC ...... unresectable pancreatic cancer

@en

Predictive value of ERCC1, ERC ...... unresectable pancreatic cancer

@nl

P1476

Predictive value of ERCC1, ERC ...... unresectable pancreatic cancer

@en

P2093

Akane Hirotani

http://www.w3.org/2001/XMLSchema#string

Makoto Sugimori

http://www.w3.org/2001/XMLSchema#string

Makoto Ueno

http://www.w3.org/2001/XMLSchema#string

Manabu Morimoto

http://www.w3.org/2001/XMLSchema#string

Satoshi Kobayashi

http://www.w3.org/2001/XMLSchema#string

Satoshi Moriya

http://www.w3.org/2001/XMLSchema#string

Shin Maeda

http://www.w3.org/2001/XMLSchema#string

Shinichi Ohkawa

http://www.w3.org/2001/XMLSchema#string

Shun Tezuka

http://www.w3.org/2001/XMLSchema#string

Yohei Miyagi

http://www.w3.org/2001/XMLSchema#string

P2860

DNA repair: dynamic defenders against cancer and aging

Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China

Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Toxicity and response criteria of the Eastern Cooperative Oncology Group

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Excision repair cross complementing-group 1: gene expression and platinum resistance.

P304

2096-2105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416859

http://www.w3.org/2001/XMLSchema#string

P932

6220150

http://www.w3.org/2001/XMLSchema#string